Publications by authors named "Francesco Merli"

Claim this Profile
I
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial.
Emanuele Zucca, Luca Ceriani, Giovannino Ciccone, Alice Di Rocco, Maria Cristina Pirosa, Francesco Merli

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial.
Riccardo Moia, Simone Ragaini, Luciano Cascione, Andrea Rinaldi, Elisa Genuardi, Francesco Merli

Leukemia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study.
Nicola Polverelli, Caterina Zerbi, Maria Grazia Benevento, Mattia Algeri, Alessandra Algarotti, Francesco Merli

Am J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study.
Carlo Visco, Valentina Tabanelli, Maria Vittoria Sacchi, Andrea Evangelista, Francesca Maria Quaglia, Anna Merli, Francesco Merli

Lancet Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ study.
Alessandra Tucci, Alessandro Re, Chiara Pagani, Luigi Marcheselli, Raffaella Marcheselli, Francesco Merli

Leuk Lymphoma· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group.
Carmen Martínez, Irma Khvedelidze, Mathilde Fekom, Benedicte Deau Fischer, Amira Marouf, Francesco Merli

Bone Marrow Transplant· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of R-miniCOMP Versus R-miniCHOP in Older Non-Fit Patients With Diffuse Large B-Cell Lymphoma: Insights From a "Fondazione Italiana Linfomi" Cohort Study.
Alberto Bavieri, Sara Veronica Usai, Michele Merli, Alice Di Rocco, Federica Cavallo, Francesco Merli

Hematol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Analysis of R-COMP Therapy in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Assessing the Impact of Sample Selection Bias.
Chiara Romano, Francesco Branda, Nicola Petrosillo, Annalisa Arcari, Francesco Merli

J Clin Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results.
Maurizio Martelli, Luca Ceriani, Giovannino Ciccone, Umberto Ricardi, Iryna Kriachok, Francesco Merli

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Anastasios Stathis, Maria Cristina Pirosa, Lorella Orsucci, Pierre Feugier, Monica Tani, Francesco Merli, Michele Merli

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical Presentation of Invasive Aspergillosis during Treatment with Mogamulizumab.
Paolo Pavone, Laura Arletti, Fiorella Ilariucci, Tommaso Albano, Deborah Lusetti, Francesco Merli

J Fungi (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial.
Alessandro Pulsoni, Simone Ferrero, Maria Elena Tosti, Stefano Luminari, Alessandra Dondi, Francesco Merli

Lancet Haematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma.
Annarita Conconi, Annalisa Chiappella, Andrés J M Ferreri, Anastasios Stathis, Barbara Botto, Francesco Merli

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study.
Francesca Romana Mauro, Potito Rosario Scalzulli, Lydia Scarfò, Carla Minoia, Roberta Murru, Francesco Merli

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma.
Massimo Federico, Catherine Fortpied, Yana Stepanishyna, Manuel Gotti, Richard van der Maazen, Francesco Merli

J Clin Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Geriatric Assessment in the Management of Diffuse Large B-Cell Lymphoma.
Francesco Merli, Stefano Pozzi, Hillary Catellani, Emiliano Barbieri, Stefano Luminari

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma.
Loretta J Nastoupil, Georg Hess, Miguel A Pavlovsky, Iwona Danielewicz, Jane Freeman, Francesco Merli

Blood Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Guido Gini, Monica Tani, Alessandra Tucci, Luigi Marcheselli, Marina Cesaretti, Francesco Merli

Blood· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib: a new first-line strategy in autoimmune myelofibrosis treatment.
Domenico Penna, Alessia Tieghi, Riccardo Valli, Francesco Merli

Leuk Lymphoma· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi & Società Italiana della Riproduzione Umana.
Carla Minoia, Simonetta Viviani, Erica Silvestris, Simone Palini, Francesca Parissone, Francesco Merli

Front Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL.
Maria Chiara Tisi, Riccardo Moia, Caterina Patti, Andrea Evangelista, Simone Ferrero, Francesco Merli

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma.
Annalisa Arcari, Lugi Rigacci, Alessandra Tucci, Benedetta Puccini, Sara Veronica Usai, Michele Merli, Francesco Merli

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study.
Lorenz Thurner, Marita Ziepert, Christian Berdel, Christian Schmidt, Peter Borchmann, Francesco Merli

Hemasphere· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020.
Lucia Mangone, Domenico Penna, Francesco Marinelli, Francesca Roncaglia, Isabella Bisceglia, Francesco Merli

Front Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Manuel Gotti, Roberta Sciarra, Alessandro Pulsoni, Francesco Merli, Stefano Luminari, Michele Merli

Hemasphere· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis